Insulin and sulphonylurea in the therapy of type 2 diabetes.

[1]  J. Stengård,et al.  Effects of enzyme induction therapy on glucose and drug metabolism in obese mice model of non-insulin dependent diabetes mellitus. , 1989, Diabetes research.

[2]  P. Casner.  Insulin‐glyburide combination therapy for non‐insulin‐dependent diabetes mellitus: A long‐term double‐blind, placebo‐controlled trial , 1988, Clinical pharmacology and therapeutics.

[3]  G. Paolisso,et al.  The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion. , 1987, Acta endocrinologica.

[4]  R. Tattersall,et al.  When to use insulin in the maturity onset diabetic. , 1987, Postgraduate medical journal.

[5]  R. Holman,et al.  Sulphonylurea Failure in Type 2 Diabetes: Treatment with a Basal Insulin Supplement , 1987, Diabetic medicine : a journal of the British Diabetic Association.

[6]  A. Kitabchi,et al.  Combined Therapy of Insulin and Tolazamide Decreases Insulin Requirement and Serum Triglycerides in Obese Patients with Noninsulin‐Dependent Diabetes Mellitus , 1987, The American journal of the medical sciences.

[7]  D. Schade,et al.  Addition of sulfonylurea to insulin treatment in poorly controlled type II diabetes. A double-blind, randomized clinical trial. , 1987, JAMA.

[8]  V. Mohan,et al.  Changes in Insulin Resistance With Long-Term Insulin Therapy , 1987, Diabetes Care.

[9]  D. Giugliano,et al.  Combined insulin and sulfonylurea therapy in non-insulin-dependent diabetics with secondary failure to oral drugs: a one year follow-up. , 1986, Diabete & metabolisme.

[10]  S. Heller,et al.  Starting insulin treatment as an outpatient. Report of 100 consecutive patients followed up for at least one year. , 1986, JAMA.

[11]  D. B. Martin,et al.  Type II Diabetes , 1986 .

[12]  O. Owen,et al.  Insulin and a sulfonylurea agent in non-insulin-dependent diabetes mellitus. , 1986, Archives of internal medicine.

[13]  H. Lebovitz,et al.  Treatment of poorly regulated non-insulin-dependent diabetes mellitus with combination insulin-sulfonylurea. , 1985, Archives of internal medicine.

[14]  G. Boden.  Treatment strategies for patients with non-insulin-dependent diabetes mellitus. , 1985, The American journal of medicine.

[15]  G. Reaven,et al.  Glyburide in non-insulin-dependent diabetes. Its therapeutic effect in patients with disease poorly controlled by insulin alone. , 1985, Archives of internal medicine.

[16]  G. Reaven.  Beneficial Effect of Moderate Weight Loss in Older Patients with Non‐Insulin‐dependent Diabetes Mellitus Poorly Controlled with Insulin , 1985, Journal of the American Geriatrics Society.

[17]  R. Tattersall,et al.  The difficult choice of treatment for poorly controlled maturity onset diabetes: tablets or insulin? , 1984, British medical journal.

[18]  L. Groop,et al.  The combination of insulin and sulphonylurea in the treatment of secondary drug failure in patients with type II diabetes. , 1984, Acta endocrinologica.

[19]  P. Salmela,et al.  Liver Function Tests in Diabetic Patients , 1984, Diabetes Care.

[20]  J. A. Scarlett,et al.  The Acute and Chronic Effects of Sulfonylurea Therapy in Type II Diabetic Subjects , 1984, Diabetes.

[21]  P. Salmela,et al.  Hepatic microsomal enzyme activity in patients with non-insulin dependent diabetes mellitus (NIDDM) and its clinical significance , 1983 .

[22]  J. Stengård,et al.  Treatment of noninsulin‐dependent diabetes mellitus with enzyme inducers , 1983, Clinical pharmacology and therapeutics.

[23]  R. DeFronzo,et al.  New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus. , 1983, The American journal of medicine.

[24]  J. A. Scarlett,et al.  Insulin Treatment Reverses the Insulin Resistance of Type II Diabetes Mellitus , 1982, Diabetes Care.

[25]  H. Beck-Nielsen,et al.  Increased insulin sensitivity and cellular insulin binding in obese diabetics following treatment with glibenclamide. , 1979, Acta endocrinologica.

[26]  K. Gerbitz,et al.  Method for rapid quantitation and characterization of insulin antibodies. , 1978, Clinical chemistry.

[27]  E. Haupt,et al.  [Secondary failures in modern therapy of diabetes mellitus with blood glucose lowering sulfonamides (author's transl)]. , 1977, Medizinische Klinik.

[28]  R. Bressler,et al.  Clinical Pharmacology of Oral Antidiabetic Agents , 1977 .

[29]  T. Richards.  Review Body Report , 1974 .

[30]  H. Lebovitz,et al.  Endocrine and Metabolic Effects of Glybenclamide: Evidence for an Extrapancreatic Mechanism of Action , 1971, Diabetes.

[31]  H. Lebovitz,et al.  Appraisal of the extrapancreatic actions of sulfonylureas. , 1969, Archives of internal medicine.

[32]  A. Bloom.  Remission in Diabetes , 1959, British medical journal.

[33]  A. Shapiro.  The placebo effect in the history of medical treatment: implications for psychiatry. , 1959, The American journal of psychiatry.

[34]  H. Beecher,et al.  The powerful placebo. , 1955, Journal of the American Medical Association.

[35]  F. Mosteller,et al.  A study of the placebo response. , 1954, The American journal of medicine.

[36]  J. Albers,et al.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. , 1978, Journal of lipid research.

[37]  G. Reaven,et al.  Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients. , 1976, The American journal of medicine.

[38]  G. Reaven,et al.  Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? , 1976, The American journal of medicine.